Free Trial
NASDAQ:NAOV

NanoVibronix (NAOV) Stock Price, News & Analysis

$0.59
+0.05 (+9.23%)
(As of 09/6/2024 ET)
Today's Range
$0.54
$0.63
50-Day Range
$0.53
$0.80
52-Week Range
$0.52
$2.91
Volume
18,585 shs
Average Volume
60,548 shs
Market Capitalization
$1.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NAOV stock logo

About NanoVibronix Stock (NASDAQ:NAOV)

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.

NAOV Stock Price History

NAOV Stock News Headlines

War on Elon Escalates…
A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
NanoVibronix Issues Letter to Stockholders
War on Elon Escalates…
A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
NanoVibronix Issues Letter to Stockholders
NanoVibronix, Inc. (NAOV)
NanoVibronix Inc NAOV
NanoVibronix Featured in Your Bladder Health Magazine
See More Headlines
Receive NAOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoVibronix and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/14/2024
Today
9/07/2024
Next Earnings (Estimated)
11/11/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NAOV
Employees
20
Year Founded
N/A

Profitability

Net Income
$-3,710,000.00
Pretax Margin
-82.75%

Debt

Sales & Book Value

Annual Sales
$3.37 million
Book Value
$1.02 per share

Miscellaneous

Free Float
2,684,000
Market Cap
$1.65 million
Optionable
Not Optionable
Beta
1.53
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Brian M. Murphy (Age 67)
    CEO & Director
    Comp: $342.5k
  • Mr. Stephen R. Brown CPA (Age 68)
    Chief Financial Officer
    Comp: $276.5k
  • Dr. Harold Jacob M.D. (Age 70)
    Chief Medical Officer & Director
  • Mr. Amir Rippel
    Vice President of Marketing
  • Ms. Lindsey Harrison
    Vice President of Sales

NAOV Stock Analysis - Frequently Asked Questions

How have NAOV shares performed this year?

NanoVibronix's stock was trading at $1.15 at the beginning of 2024. Since then, NAOV shares have decreased by 48.5% and is now trading at $0.5919.
View the best growth stocks for 2024 here
.

How were NanoVibronix's earnings last quarter?

NanoVibronix, Inc. (NASDAQ:NAOV) posted its quarterly earnings results on Wednesday, August, 14th. The company reported ($0.25) earnings per share for the quarter. The business had revenue of $0.82 million for the quarter. NanoVibronix had a negative trailing twelve-month return on equity of 74.98% and a negative net margin of 83.49%.

When did NanoVibronix's stock split?

Shares of NanoVibronix split on Thursday, October 13th 2022. The 2-1 split was announced on Thursday, October 13th 2022. The newly created shares were distributed to shareholders after the closing bell on Thursday, October 13th 2022. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Who are NanoVibronix's major shareholders?

NanoVibronix's top institutional investors include Armistice Capital LLC (4.92%). Insiders that own company stock include Christopher M Fashek and Aurora Cassirer.
View institutional ownership trends
.

How do I buy shares of NanoVibronix?

Shares of NAOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of NanoVibronix own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NanoVibronix investors own include T2 Biosystems (TTOO), ADMA Biologics (ADMA), Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP) and BIO-key International (BKYI).

This page (NASDAQ:NAOV) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners